3rd generation lenti vector encoding dCAS9-VP64 with 2A Blast resistance marker (EF1a-NLS-dCas9(N863)-VP64-2A-Blast-WPRE)

Arabinose inducible E. coli codon optimized superfolder GFP with C-terminal His6 tag

N-terminal EGFP tag. Gateway destination vector for lentivirus production and stable transduction in mammalian cells.

TDP-43 with a C-terminal mRuby tag for expression in mammalian cells.

AAV genome encoding SauriABE8e and Sa sgRNA cassette on a single AAV, with BsmBI sites for protospacer installation

2nd generation lentiviral transfer plasmid. Expresses a synthetic cluster of miR-9/9* and miR-124 fused to Bcl-xL under a doxycycline-inducible promoter

mini-Tn7 base vector with transcriptional terminator and oriT

Expresses mStayGold targeted to the mitochondria

Expresses the Timer protein targeted to the mitochondria under a Tet-inducible promoter

3rd generation, Inducible lentiviral expression, TRE-gateway; PGK-rtTA-2A-puro

AAV expression of jRGECO1a, a red fluorescent calcium sensor protein, from the Synapsin promoter

2nd generation lentiviral transfer plasmid. Expresses human MYT1L with G418 resistance

Ready-to-use AAV1 particles produced from pAAV.hSynap.iGABASnFR (#112159). In addition to the viral particles, you will also receive purified pAAV.hSynap.iGABASnFR plasmid DNA. Synapsin-driven iGABASnFR GABA sensor. These AAV preparations are suitable purity for injection into animals.

For C-terminal tagging with TurboID in yeast including nourseothricin-resistant marker

Ready-to-use AAV Retrograde particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

dCas9 with an N-term Zim3 KRAB-NLS fusion, a C-term HA-2xNLS

Mammalian expression of Cre recombinase from the broadly active CAG promoter/enhancer